Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors

Serum Cystatin C Level Is Not a Promising Biomarker for Predicting Clinicopathological Characteristics of Bladder Urothelial Tumors

The role of cystatin C (Cys-C) in tumorigenesis and progression of bladder urothelial tumors (BUT) is still indefinite. We retrospectively collected the clinical information from the records of 425 BUT patients. Pretreatment serum Cys-C levels were compared across the various groups. Then we subgrou...

Full description

Bibliographic Details
Main Authors:	Hui Wang, Lijian Gao, Cuiyu Meng, Nengwang Yu, Feilong Yang, Cong Zhang, Dawei Li, Lei Yan, Hainan Liu, Zhonghua Xu
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2018/2617439

Similar Items

Pretreatment Serum Cystatin C Levels Predict Renal Function, but Not Tumor Characteristics, in Patients with Prostate Neoplasia
by: Feilong Yang, et al.
Published: (2017-01-01)

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
by: Shuxiong Zeng, et al.
Published: (2017-06-01)

: A Promising Biomarker for Urothelial Carcinoma
by: ZhongFa Zhang, et al.
Published: (2011-01-01)

On the correlation between serum Cystatin C and Parkinson’s disease in the Chinese population: a promising biomarker?
by: Chang-Gui Yang, et al.
Published: (2021-06-01)

Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer
by: Alberto Valdés, et al.
Published: (2021-04-01)

Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
by: Nada Humayun-Zakaria, et al.
Published: (2019-03-01)

FXYD3: A Promising Biomarker for Urothelial Carcinoma
by: ZhongFa Zhang, et al.
Published: (2011-02-01)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
by: Elena A. Gashenko, et al.
Published: (2013-08-01)

Serum Homocysteine, cystatin C as Biomarkers for Progression of Diabetic Nephropathy
by: Xu Weihai, et al.
Published: (2019-12-01)

Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma
by: Dong Fang, et al.
Published: (2018-03-01)

Serum Cystatin C as a Biomarker in Diffuse Large B-Cell Lymphoma
by: Nada E. Hammouda, et al.
Published: (2017-03-01)

Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma.
by: Shengjie Guo, et al.
Published: (2017-01-01)

Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
by: Feilong Yang, et al.
Published: (2018-01-01)

Sarcomatoid variant urothelial carcinoma of the bladder: a systematic review and meta-analysis of the clinicopathological features and survival outcomes
by: Liangyou Gu, et al.
Published: (2020-11-01)

Prognostic values of the clinicopathological characteristics and survival outcomes in micropapillary urothelial carcinoma of the bladder: A SEER database analysis
by: Di Jin, et al.
Published: (2020-07-01)

PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma
by: Liu M, et al.
Published: (2021-09-01)

Cancer Antigen 15-3 Serum Level as a Biomarker for Advanced Micropapillary Urothelial Carcinoma of the Bladder: A Case Report
by: Koichiro Takayama, et al.
Published: (2021-06-01)

Utility of cystatin C as a potential bladder tumour biomarker confirmed by surface plasmon resonance technique
by: Anna Tokarzewicz, et al.
Published: (2018-01-01)

Early Detection of Renal Impairment by Biomarkers Serum Cystatin C and Creatinine in Saudi Arabia
by: Moh’d Alaraj, et al.
Published: (2017-02-01)

Grading of urothelial carcinoma of the bladder
by: M. V. Kovylina, et al.
Published: (2017-06-01)

Plasmacytoid urothelial carcinoma of the bladder
by: Meihua Qin, et al.
Published: (2014-01-01)

Chromium in urothelial carcinoma of the bladder
by: Tomasz Golabek, et al.
Published: (2017-12-01)

WHO/ISUP classification of the urothelial tumors of the urinary bladder
by: Zdenka Ovčak
Published: (2005-09-01)

A Novel Biomarker Based on miRNA to Predict the Prognosis of Muscle-Invasive Bladder Urothelial Carcinoma
by: Yueyi Feng, et al.
Published: (2019-01-01)

Functional Genomics Profiling of Bladder Urothelial Carcinoma MicroRNAome as a Potential Biomarker
by: Wei Tse Li, et al.
Published: (2018-04-01)

Evidence for Bladder Urothelial Pathophysiology in Functional Bladder Disorders
by: Susan K. Keay, et al.
Published: (2014-01-01)

Serum microRNAs are promising novel biomarkers.
by: Shlomit Gilad, et al.
Published: (2008-09-01)

Serum Beta 2-Microglobulin/Cystatin C Index: A Useful Biomarker in Lupus Nephritis
by: Marcus Vinicius Madureira Silva, et al.
Published: (2012-06-01)

Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder
by: Donghyun Kim, et al.
Published: (2020-04-01)

Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma
by: Huang CK, et al.
Published: (2018-04-01)

Giant Cell Urothelial Carcinoma of Bladder
by: Harshima Disvini Wijesinghe, et al.
Published: (2021-01-01)

An epidemiologic study on urothelial carcinomas of bladder
by: Ayşenur Keleş, et al.
Published: (2011-09-01)

Urothelial cancers of the bladder in young people
by: Živković Slađana, et al.
Published: (2003-01-01)

Cutaneous metastasis of bladder urothelial carcinoma
by: Osamah Hasan, et al.
Published: (2020-01-01)

Bladder melanosis with concurrent urothelial carcinoma
by: Susanna E. Yau, et al.
Published: (2017-11-01)

Intravesical therapy for urothelial carcinoma of the bladder
by: M Manoharan
Published: (2011-01-01)

Urothelial Carcinoma of the Bladder: Radiologic Perspective
by: Dong Won Kim, et al.
Published: (2021-09-01)

The role of the urothelial mucosa in bladder mechanosensation
by: Liaskos, Marina
Published: (2016)

Combined Genetic Biomarkers Confer Susceptibility to Risk of Urothelial Bladder Carcinoma in a Saudi Population
by: Nasser Attia Elhawary, et al.
Published: (2017-01-01)

Long non-coding RNA urothelial carcinoma–associated 1 as a tumor biomarker for the diagnosis of urinary bladder cancer
by: Zichun Wang, et al.
Published: (2017-06-01)

Cannot write session to /tmp/vufind_sessions/sess_admrhlk0coa4b8jfvuhg47ojtk